8 results on '"Eurola, Annika"'
Search Results
2. Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
- Author
-
Eurola, Annika, Ristimäki, Ari, Mustonen, Harri, Nurmi, Anna-Maria, Hagström, Jaana, Haglund, Caj, and Seppänen, Hanna
- Published
- 2021
- Full Text
- View/download PDF
3. Associations between the aetiology of preterm birth and mortality and neurodevelopment up to 11 years.
- Author
-
Grönroos, Linda, Rautava, Päivi, Setänen, Sirkku, Nyman, Anna, Ekholm, Eeva, Lehtonen, Liisa, Ylijoki, Milla, Ekblad, Mikael, Ekblad, Satu, Eurola, Annika, Haataja, Leena, Haveri, Laura, Helin, Minttu, Huhtala, Mira, Jaakkola, Jere, Joensuu, Eveliina, Karukivi, Max, Kero, Pentti, Korja, Riikka, and Lahti, Katri
- Subjects
PREMATURE labor ,PREMATURE rupture of fetal membranes ,VERY low birth weight ,ETIOLOGY of diseases ,NEURAL development - Abstract
Aim: To investigate how the aetiology of very preterm birth/very low birth weight is associated with mortality and later neurodevelopmental outcomes. Methods: Very preterm/very low‐birth weight singletons were categorised based on the aetiology of preterm birth: spontaneous preterm birth (n = 47, 28.1%), preterm premature rupture of membranes (n = 56, 33.5%) or placental vascular pathology (n = 64, 38.3%). Mortality, cerebral palsy, severe cognitive impairment by 11 years of age (<2SD) and mean full‐scale intelligence quotient at 11 years were studied in association with birth aetiology. Results: There was no difference in mortality or rate of cerebral palsy according to birth aetiologies. The rate of severe cognitive impairment was lower (4.9% vs. 15.3%) in the preterm premature rupture of the membrane group in comparison to the placental vascular pathology group (OR 0.2, 95% CI 0.03–0.9, adjusted for gestational age). At 11 years, there was no statistically significant difference in the mean full‐scale intelligence quotient. Conclusion: Placental vascular pathology, as the aetiology of very preterm birth/very low birth weight, is associated with a higher rate of severe cognitive impairments in comparison to preterm premature rupture of membranes, although there was no difference in the mean full‐scale intelligence quotient at 11 years. The aetiology of very preterm birth/very low birth weight was not associated with mortality or the rate of cerebral palsy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Treatment response and thromboembolic complications in neoadjuvant-treated pancreatic cancer
- Author
-
Eurola, Annika, University of Helsinki, Faculty of Medicine, Doctoral Program in Clinical Research, Kirurgia, HUS, Patologia, HUS, Translationaalisen lääketieteen ohjelma, Helsingin yliopisto, lääketieteellinen tiedekunta, Kliininen tohtoriohjelma, Helsingfors universitet, medicinska fakulteten, Doktorandprogrammet i klinisk forskning, Laukkarinen, Johanna, and Seppänen, Hanna
- Subjects
lääketiede - Abstract
Pancreatic ductal adenocarcinoma, the most typical pancreatic malignancy, is usually referred to as pancreatic cancer. With a 5-year survival rate of 10%, it is the third most common cancer-related cause of death. The poor survival rate is due to the aggressive and systemic nature of the disease, lack of early symptoms, and strong therapeutic resistance. These factors also enable the survival rate as low as 25% for resectable disease. Neoadjuvant therapy (NAT) offers a systemic treatment solution administered early in the treatment course before surgery. NAT improves the survival of surgically treated patients. The use of NAT will increase in the future. However, the histological treatment response rates remain low. Additionally, to the aggressive nature of the disease, pancreatic cancer is one of the most prothrombotic cancers, with venous thromboembolism (VTE) incidence rates up to 40%. VTE is a fatal complication of cancer, and factors such as chemotherapy and abdominal surgery increase the risk of VTE in pancreatic cancer. Patients experiencing VTE have shorter overall survival and more morbidity. The studies in this thesis explored the histological NAT response rates and examined the factors associated with a strong response, hence analyzing who is to benefit from NAT. Additionally, markers for response were analyzed, and histological changes in the tumors of responders were investigated. The thesis examined the prognostic histological markers of neoadjuvant-treated pancreatic cancer. Further, the thesis explored the burden of VTE in neoadjuvant-treated pancreatic cancer patients and the factors associated with VTE. These studies show that a strong NAT response remains rare and that only the strongly responding patients benefit from NAT in terms of survival. The thesis demonstrates the differences in histological marker expressions of podocalyxin, beta-catenin, and PROX1 between treatment response groups. Furthermore, it establishes the associations of the markers with patient survival by investigating the differences in the associations between response groups. Additionally, it shows the increased burden of VTE amongst NAT patients compared to patients with upfront surgery and enlightens the factors associated with VTE. Haimasyövästä puhuttaessa tarkoitetaan yleensä haiman duktaalista adenokarsinoomaa, joka on haiman yleisin pahanlaatuinen tauti. Haimasyöpä aiheuttaa kolmanneksi eniten syöpäliitännäisiä kuolemia, ja sen 5-vuotis eloonjäämisennuste on 10 %. Huono ennuste johtuu taudin aggressiivisesta ja systeemisestä luonteesta, aikaisin ilmaantuvien oireiden puutteesta ja vahvasta hoitoresistenssistä. Nämä tekijät johtavat niinkin matalaan kuin 20 %:n 5-vuotis eloonjäämisennusteen myös leikkauskelpoisilla potilailla. Neoadjuvanttihoitoa voidaan käyttää systeemisesti haimasyövän hoitoon jo aikaisessa vaiheessa ennen leikkausta. Neoadjuvanttihoito pidentää leikkauksella hoidettavien potilaiden elinajanennustetta ja sen käyttö tulee tulevaisuudessa lisääntymään. Kuitenkin hoitovasteet jäävät usein heikoksi. Taudin aggressiivisen luonteen lisäksi haimasyöpä on myös yksi eniten verisuonitukoksia aiheuttavista syövistä ja jopa 40 % haimasyöpäpotilaista voi saada laskimotukoksen. Laskimotukos on kuolettava syövän komplikaatio, joka lyhentää elinaikaa ja lisää sairastavuutta. Esimerkiksi kemoterapia ja leikkaukset kasvattavat tukosriskiä haimasyöpäpotilailla. Tässä väitöstutkimuksessa tutkittiin neoadjuvanttihoidon vasteita ja tekijöitä, jotka ovat yhteydessä vahvaan hoitovasteeseen selvittäen, kuka hyötyisi neoadjuvanttihoidosta. Lisäksi tutkittiin neoadjuvanttipotilaiden histologisia ennuste- ja vastemerkkiaineita sekä histologisia muutoksia hyvän hoitovasteen kasvaimissa. Edelleen analysoitiin neoadjuvanttihoidon aiheuttamia laskimotukoskomplikaatioita ja laskimotukokseen yhdistyviä tekijöitä. Tutkimukset osoittavat, että vahva neoadjuvanttivaste on harvinainen, ja että eloonjäämislukuja tarkastellen vain vahvan hoitovasteen omaavat potilaat hyötyvät neoadjuvantista. Väitöskirja demonstroi erot histologisten merkkiaineiden, podocalyxiinin, beta-cateniinin ja PROX1:n ekspressiossa eri hoitovasteryhmien välillä. Lisäksi tutkimukset demonstroivat yhteyden merkkiaineiden ekspressiossa ja ennusteessa tutkien eroja näissä yhteyksissä eri vasteryhmien välillä. Väitöskirja osoittaa, että neoadjuvanttihoidetuilla potilailla on lisääntynyt laskimotukosriski suoraan leikattuihin potilaisiin verrattuna ja erottelee tekijöitä, jotka ovat liitännäisiä laskimotukokseen.
- Published
- 2022
5. Web-based follow-up tool (ePIPARI) of preterm infants—study protocol for feasibility and performance.
- Author
-
Saarinen, Tiina, Ylijoki, Milla, Lehtonen, Liisa, Munck, Petriina, Stolt, Suvi, Lapinleimu, Helena, Rautava, Päivi, Haataja, Leena, Setänen, Sirkku, Leppänen, Marika, Huhtala, Mira, Saarinen, Katriina, Grönroos, Linda, Korja, Riikka, Ekblad, Mikael, Ekblad, Satu, Ekholm, Eeva, Eurola, Annika, Haveri, Laura, and Helin, Minttu
- Subjects
PREMATURE infants ,RESEARCH protocols ,PARENT-infant relationships ,WELL-being ,CHILDREN'S health - Abstract
Background: Preterm infants have a risk of health and developmental problems emerging after discharge. This indicates the need for a comprehensive follow-up to enable early identification of these problems. In this paper, we introduce a follow-up tool "ePIPARI – web-based follow-up for preterm infants". Our future aim is to investigate whether ePIPARI is a feasible tool in the follow-up of preterm infants and whether it can identify children and parents in need of clinical interventions. Methods: ePIPARI includes eight assessment points (at term age and at 1, 2, 4, 8, 12, 18, and 24 months of corrected age) when the child´s health and growth, eating and feeding, neurodevelopment, and parental well-being are evaluated. ePIPARI consists of several widely used, standardized questionnaires, in addition to questions typically presented to parents in clinical follow-up visits. It also provides video guidance and written information about age-appropriate neurodevelopment for the parents. Parents of children born before 34 weeks of gestation during years 2019–2022 are being invited to participate in the ePIPARI study, in which web-based follow-up with ePIPARI is compared to clinical follow-up. In addition, the parents of children born before 32 weeks of gestation, who reached the corrected age of two years during 2019–2021 were invited to participate for the assessment point of 24 months of ePIPARI. The parents are asked to fill in the online questionnaires two weeks prior to each clinical follow-up visit. Discussion: The web-based tool, ePIPARI, was developed to acquire a sensitive and specific tool to detect infants and parents in need of further support and clinical interventions. This tool could allow individualized adjustments of the frequency and content of the clinical visits. Trial registration: ClinicalTrials.cov, NCT05238168. Registered 11 April 2022 – Retrospectively registered. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. β-catenin plus PROX1 immunostaining stratifies disease progression and patient survival in neoadjuvant-treated pancreatic cancer
- Author
-
Eurola, Annika, primary, Ristimäki, Ari, additional, Mustonen, Harri, additional, Nurmi, Anna-Maria, additional, Hagström, Jaana, additional, Kallio, Pauliina, additional, Alitalo, Kari, additional, Haglund, Caj, additional, and Seppänen, Hanna, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
- Author
-
Eurola, Annika, primary, Mustonen, Harri, additional, Mattila, Nora, additional, Lassila, Riitta, additional, Haglund, Caj, additional, and Seppänen, Hanna, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Prediction of neuromotor outcome in infants born preterm at 11 years of age using volumetric neonatal magnetic resonance imaging and neurological examinations.
- Author
-
Setänen, Sirkku, Lehtonen, Liisa, Parkkola, Riitta, Aho, Karoliina, Haataja, Leena, Ahtola, Annarilla, Ekblad, Mikael, Ekblad, Satu, Ekholm, Eeva, Eurola, Annika, Huhtala, Mira, Kero, Pentti, Kiiski‐Mäki, Hanna, Korja, Riikka, Lahti, Katri, Lapinleimu, Helena, Lehtonen, Tuomo, Leppänen, Marika, Lind, Annika, and Manninen, Hanna
- Subjects
MOTOR neurons ,MAGNETIC resonance imaging of the brain ,PREMATURE infants ,BASAL ganglia ,CEREBELLUM ,FRONTAL lobe ,HEALTH ,PHYSIOLOGY ,DIAGNOSIS of developmental disabilities ,PREMATURE infant diseases ,MOVEMENT disorders ,BRAIN ,GESTATIONAL age ,DIGITAL image processing ,MAGNETIC resonance imaging ,NEUROLOGIC examination ,HEALTH outcome assessment ,PREDICTIVE tests ,DIAGNOSIS - Abstract
Aim: To study the prognostic value of volumetric brain magnetic resonance imaging (MRI) at term equivalent age (TEA) and neurological examinations at TEA and at 2 years of corrected age for long-term neuromotor outcome in infants born very preterm.Method: A total of 98 infants born very preterm were included. Structural and volumetric brain MRI and the Dubowitz neurologic examination were done at TEA. The Hammersmith Infant Neurological Examination (HINE) was performed at 2 years of corrected age. The Touwen examination was used for the assessment of minor neurological dysfunction (MND) at the age of 11 years.Results: Of all children (median birthweight 1083g [quartiles 820, 1300]; gestational age 28 5/7wks [26 4/7, 30 2/7]), 41 had simple MND, 11 had complex MND (cMND), and eight had cerebral palsy (CP). The negative and positive predictive value of structural brain MRI for cMND or CP was 88% and 50% respectively. Reduced volumes of total brain tissue, frontal lobes, basal ganglia and thalami, and cerebellum associated with cMND or CP. The results of the Dubowitz neurologic examination and the HINE correlated with the Touwen examination.Interpretation: Structural and volumetric MRI at TEA and structured neurological examinations predict long-term neuromotor outcome in infants born preterm. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.